Puma Biotechnology (PBYI) Work In Process (2020 - 2026)

Puma Biotechnology has reported Work In Process for 7 years, with the latest figure at $1.9 million in Q1 2026.

• For the quarter ending Q1 2026, Work In Process rose 80.36% year-over-year to $1.9 million; the trailing twelve-month figure through Mar 2026 stood at $1.9 million (up 80.36% YoY), and the FY2025 full-year result was $1.3 million, up 77.18% from the prior year.
• Work In Process for Q1 2026 stood at $1.9 million, up from $1.3 million in the prior quarter.
• The five-year high for Work In Process was $7.8 million in Q2 2024, with the low at $758000.0 in Q4 2024.
• Historically, Work In Process has averaged $2.5 million across 5 years, with a median of $2.0 million in 2024.
• The largest YoY upside for Work In Process was 169.08% in 2025 against a maximum downside of 82.89% in 2025.
• Puma Biotechnology's Work In Process stood at $2.7 million in 2022, then plunged by 69.18% to $820000.0 in 2023, then fell by 7.56% to $758000.0 in 2024, then soared by 77.18% to $1.3 million in 2025, then soared by 43.56% to $1.9 million in 2026.
• The last three Work In Process figures came in at $1.9 million (Q1 2026), $1.3 million (Q4 2025), and $5.4 million (Q3 2025), per Business Quant data.